Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines

Cell Death Discovery

Volumn 1, Issue 1, 2015, Pages

  Mahbub, Aa ^a   Le Maitre, Cl ^a   Haywood Small, Sl ^a   Cross, Na ^a   Jordan Mahy, N ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85017167824     PISSN: None     EISSN: 20587716     Source Type: Journal    
DOI: 10.1038/cddiscovery.2015.43     Document Type: Article

References (32)

1. Leukaemia and lymphoma Research. Available at: https://leukaemialymphomaresearch.org.uk (accessed 08 June 2015).
2. Cancer Research UK. Let's beat cancer sooner. Available at: http://www.cancerresearchuk.org/ (accessed 08 June 2015).
3. Mohan A, Narayanan S, Sethuraman S, Maheswari Krishnan U. Combinations of plant polyphenols & anti-cancer molecules: A novel treatment strategy for cancer chemotherapy. Anticancer Agents Med Chem 2013; 13: 281–295.
4. Rossi S. Australian Medicines Handbook. The Australian Medicines Handbook Unit Trust: Adelaide, SA, Australia, 2013.
5. Thakur DS. Topoisomerase II inhibitors in cancer treatment. Int J Pharm Nanotechnol 2011; 3: 1173–1181.
6. Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 2013; 65: 157–170.
7. Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE et al. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenet Genomics 2011; 21: 440–446.
8. Mahbub AA, Le Maitre CL, Haywood-Small SL, McDougall GJ, Cross NA, Jordan-Mahy N. Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines. Anticancer Agents Med Chem 2013; 13: 1601–1613.
9. Kuhar M, Imran S, Singh N. Curcumin and quercetin combined with cisplatin to induce apoptosis in human laryngeal carcinoma hep-2 cells through the mitochondrial pathway. J Cancer Mol 2007; 3: 121–128.
10. Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. Drug combinations with quercetin: Doxorubicin plus quercetin in human breast cancer cells. Cancer Chemotherap Pharmacol 2011; 68: 1161–1172.
11. Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M et al. Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. Int Immunopharmacol 2010; 10: 819–826.
12. Li SZ, Qiao HF, Zhang JH, Li K. Quercetin increase the chemosensitivity of breast cancer cells to doxorubicin via PTEN/Akt pathway. Anticancer Agents Med Chem 2015; 15: 1185–1189.
13. Wang G, Zhang J, Liu L, Sharma S, Dong Q. Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl. PLoS One 2012; 7: e51764.
14. Brantley E, Amis L, Davis W. Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients. Cancer Epidemiol Biomarkers Prev 2007; 16: B81–B81.
15. Samuel T, Fadlalla K, Mosley L, Katkoori V, Turner T, Manne U. Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells. Anticancer Res 2012; 32: 61–71.
16. An WG, Hwang SG, Trepel JB, Blagosklonny MV. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 2000; 14: 1276–1283.
17. Durland-Busbice S, Reisman D. Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene. Leukemia 2002; 16: 2165–2167.
18. Geley S, Hartmann BL, Hattmannstorfer R, Loffler M, Ausserlechner MJ, Bernhard D et al. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene 1997; 15: 2429–2437.
19. Čipák L, Novotný L, Čipáková I, Rauko P. Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids. Nutrition Res 2003; 23: 1045–1057.
20. Kim TY, Park J, Oh B, Min HJ, Jeong T. Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction. Br J Haematol 2009; 146: 270–281.
21. Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010; 2: 1231–1246.
22. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013; 20: 972913.
23. Irwin ME, Rivera-Del VN, Chandra J. Redox control of leukemia: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2013; 18: 1349–1383.
24. Luceri C, Caderni G, Sanna A, Dolara P. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr 2002; 132: 1376–1379.
25. Franco R, Cidlowski J. Apoptosis and glutathione: beyond an antioxidant. Cell Death Diff 2009; 16: 1303–1314.
26. Brechbuhl HM, Kachadourian R, Min E, Chan D. Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione. Toxicol Appl Pharmacol 2012; 258: 1–9.
27. Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers 2011; 3: 1285–1310.
28. Wilson TR, Longley DB, Johnston PG. Chemoresistance in solid tumours. Ann Oncol 2006; 17: 315–324.
29. Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenet 2011; 3: 4.
30. Kuo LJ, Yang LX. Gamma-H2AX—a novel biomarker for DNA double-strand breaks. In Vivo 2008; 22: 305–309.
31. Solier S, Pommier Y. The apoptotic ring: a novel entity with phosphorylated histones H2AX and H2B, and activated DNA damage response kinases. Cell Cycle 2009; 8: 1853–1859.
32. Rakiman I, Chinnadurai M, Baraneedharan U, Solomon F, Venkatachalam P. Gamma-H2AX assay: a technique to quantify DNA double strand breaks. Adv Biotechnol 2008; 39–41.